PharmaCyte Biotech, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

1topics both disclose

3only PharmaCyte Biotech, Inc.

3only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	PharmaCyte Biotech, Inc.	4D Molecular Therapeutics, Inc.
Internal Control	8	6

Only PharmaCyte Biotech, Inc.

Topic	Filings
Material Weakness	5
Enforcement Action	1
Regulatory Investigation	1

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Restatement	5
Ransomware	3
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

PharmaCyte Biotech, Inc. · 4D Molecular Therapeutics, Inc. · All companies